Compare ARK Genomic Revolution ETF (ARKG) vs iShares MSCI Hong Kong ETF (EWH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MSCI Hong Kong ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while iShares MSCI Hong Kong ETF trades at $21.55. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EWH | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $24.55 |
52-Week Low | $23.09 | $20.09 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EWH trades at $21.50, up 1.37% over the past 24 hours, with technical indicators showing a bearish bias from moving averages and oscillators in neutral territory. The stock faces resistance and support clustered around $21, indicating consolidation. Recent news highlights Hong Kong market rallies and regulatory developments affecting sentiment.
Outlook remains cautious due to mixed technical signals and limited fundamental data. Risks include regulatory scrutiny and market volatility, but potential exists from Hong Kong's financial hub growth. Investors should weigh technical resistance against broader market trends for entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MSCI Hong Kong ETF
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →
